Platelet-Lymphocyte Ratio as a Useful Predictor of the Therapeutic Effect of Neoadjuvant Chemotherapy in Breast Cancer.

Platelet-Lymphocyte Ratio as a Useful Predictor of the Therapeutic Effect of Neoadjuvant Chemotherapy in Breast Cancer.

The peripheral blood platelet-lymphocyte ratio (PLR) has been proposed as an indicator for evaluating systemic inflammatory responses in cancer-bearing patients. While some reports suggest a correlation between PLR and prognosis, few studies have examined the relationship between PLR and sensitivity...

Full description

Bibliographic Details
Main Authors:	Yuka Asano, Shinichiro Kashiwagi, Naoyoshi Onoda, Satoru Noda, Hidemi Kawajiri, Tsutomu Takashima, Masahiko Ohsawa, Seiichi Kitagawa, Kosei Hirakawa
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2016-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4966926?pdf=render

Similar Items

Prediction of survival after neoadjuvant chemotherapy for breast cancer by evaluation of tumor-infiltrating lymphocytes and residual cancer burden
by: Yuka Asano, et al.
Published: (2017-12-01)

Identification of predictive markers of the therapeutic effect of eribulin chemotherapy for locally advanced or metastatic breast cancer
by: Shinichiro Kashiwagi, et al.
Published: (2017-08-01)

Mammary phyllodes tumor with six episodes of a relapse: a case report
by: Nozomi Iimori, et al.
Published: (2017-09-01)

Alveolar soft part sarcoma metastatic to the breast: a case report
by: Yuka Asano, et al.
Published: (2019-03-01)

Use of the tumor-infiltrating CD8 to FOXP3 lymphocyte ratio in predicting treatment responses to combination therapy with pertuzumab, trastuzumab, and docetaxel for advanced HER2-positive breast cancer
by: Koji Takada, et al.
Published: (2018-04-01)

Significance of intrinsic breast cancer subtypes on the long-term prognosis after neoadjuvant chemotherapy
by: Wataru Goto, et al.
Published: (2018-11-01)

Continuous intraoperative neuromonitoring for thyroid cancer surgery: A prospective study
by: Naoyoshi Onoda, et al.
Published: (2019-08-01)

Adenoid Cystic Carcinoma of the Breast: A Case Report
by: Shinichiro Kashiwagi, et al.
Published: (2019-09-01)

Pure Mucinous Breast Carcinoma with Micropapillary Pattern (MUMPC): A Case Report
by: Yuka Asano, et al.
Published: (2019-07-01)

A case of Adrenocoricotrophic hormone -independent bilateral adrenocortical macronodular hyperplasia concomitant with primary aldosteronism
by: Mao Tokumoto, et al.
Published: (2017-09-01)

Study on the progression types of cancer in patients with breast cancer undergoing eribulin chemotherapy and tumor microenvironment
by: Shinichiro Kashiwagi, et al.
Published: (2018-03-01)

Predictive value of lymphocyte-to-monocyte ratio in the preoperative setting for progression of patients with breast cancer
by: Wataru Goto, et al.
Published: (2018-11-01)

Pathological Complete Response following Neoadjuvant Chemotherapy in Invasive Ductal Carcinoma with Mammary Paget’s Disease: A Case Report
by: Wataru Goto, et al.
Published: (2021-08-01)

Circulating tumor cell clusters-associated gene plakoglobin is a significant prognostic predictor in patients with breast cancer
by: Wataru Goto, et al.
Published: (2017-05-01)

Prediction of lymph node metastasis by tumor-infiltrating lymphocytes in T1 breast cancer
by: Koji Takada, et al.
Published: (2020-06-01)

Cowden Syndrome Diagnosed by Bilateral Breast Cancer with Lhermitte-Duclos Disease: A Case Report
by: Tamami Morisaki, et al.
Published: (2020-04-01)

Possibility of avoiding axillary lymph node dissection by immune microenvironment monitoring in preoperative chemotherapy for breast cancer
by: Koji Takada, et al.
Published: (2018-11-01)

Prediction of survival after eribulin chemotherapy for breast cancer by absolute lymphocyte counts and progression types
by: Tamami Morisaki, et al.
Published: (2021-11-01)

Verification of the effects of calcium channel blockers on the immune microenvironment of breast cancer
by: Koji Takada, et al.
Published: (2019-06-01)

Clinical verification of the relationship between smoking and the immune microenvironment of breast cancer
by: Koji Takada, et al.
Published: (2019-01-01)

Breast Angiosarcoma with a Preoperative Diagnosis of Late Recurrence of Breast Cancer: A Case Report
by: Rika Kouhashi, et al.
Published: (2021-03-01)

Factors predictive of invasive ductal carcinoma in cases preoperatively diagnosed as ductal carcinoma in situ
by: Koji Takada, et al.
Published: (2020-06-01)

Prediction of distant metastatic recurrence by tumor-infiltrating lymphocytes in hormone receptor-positive breast cancer
by: Koji Takada, et al.
Published: (2021-05-01)

The effect of smoking on biological change of recurrent breast cancer
by: Koji Takada, et al.
Published: (2020-04-01)

Inhibitory effects of iron depletion plus eribulin on the breast cancer microenvironment
by: Wataru Goto, et al.
Published: (2020-12-01)

Clinical verification of body mass index and tumor immune response in patients with breast cancer receiving preoperative chemotherapy
by: Koji Takada, et al.
Published: (2021-10-01)

Clinical verification of the relationship between serum lipid metabolism and immune activity in breast cancer patients treated with neoadjuvant chemotherapy
by: Wataru Goto, et al.
Published: (2023-01-01)

Platelet-to-lymphocyte ratio as a predictive factor of complete pathologic response to neoadjuvant chemotherapy in breast cancer.
by: Javier Cuello-López, et al.
Published: (2018-01-01)

Combined neutrophil-lymphocyte ratio and platelet-lymphocyte ratio predicts chemotherapy response and prognosis in patients with advanced gastric cancer
by: Tetsushi Hirahara, et al.
Published: (2019-07-01)

Abundant intratumoral fibrosis prevents lymphocyte infiltration into peritoneal metastases of colorectal cancer.
by: En Wang, et al.
Published: (2021-01-01)

Prognostic Value of Platelet-to-Lymphocyte Ratio, Neutrophil-to-Lymphocyte Ratio, and Lymphocyte-to-White Blood Cell Ratio in Colorectal Cancer Patients Who Received Neoadjuvant Chemotherapy
by: Wangqiang Jia MD, et al.
Published: (2021-07-01)

P159 Neutrophil-to-lymphocyte Ratio and Platelet-to-lymphocyte Ratio are not predictive of Pathologic Complete Response to Neoadjuvant Chemotherapy in Triple-negative Breast Cancer
by: I. Soares de Pinho, et al.
Published: (2023-03-01)

Development and validation of a deep learning model for detection of breast cancers in mammography from multi-institutional datasets.
by: Daiju Ueda, et al.
Published: (2022-01-01)

A new method for evaluating tumor-infiltrating lymphocytes (TILs) in colorectal cancer using hematoxylin and eosin (H-E)-stained tumor sections.
by: Yasuhito Iseki, et al.
Published: (2018-01-01)

Prognostic significance of platelet-to-lymphocyte ratio (PLR) in patients with breast cancer treated with neoadjuvant chemotherapy: a meta-analysis
by: Jia Chen, et al.
Published: (2023-11-01)

A nomogram based on platelet-to-lymphocyte ratio for predicting pathological complete response of breast cancer after neoadjuvant chemotherapy
by: Rulan Ma, et al.
Published: (2023-03-01)

Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictive and prognostic markers in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiation
by: Shaan Dudani, et al.
Published: (2019-07-01)

Kimura’s disease affecting the axillary lymph nodes: a case report
by: Kenji Kuroda, et al.
Published: (2017-05-01)

Platelet-to-Lymphocyte Ratio Is Associated With Favorable Response to Neoadjuvant Chemotherapy in Triple Negative Breast Cancer: A Study on 120 Patients
by: Sejdi Lusho, et al.
Published: (2021-07-01)

Neoadjuvant chemotherapy for Ewing’s sarcoma family tumors of the uterine cervix: A case report
by: Masahiko Mori, et al.
Published: (2021-11-01)